Liantao Li

3.9k total citations · 1 hit paper
115 papers, 2.9k citations indexed

About

Liantao Li is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Liantao Li has authored 115 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 37 papers in Oncology and 22 papers in Immunology. Recurrent topics in Liantao Li's work include CAR-T cell therapy research (21 papers), Virus-based gene therapy research (16 papers) and Immunotherapy and Immune Responses (8 papers). Liantao Li is often cited by papers focused on CAR-T cell therapy research (21 papers), Virus-based gene therapy research (16 papers) and Immunotherapy and Immune Responses (8 papers). Liantao Li collaborates with scholars based in China, United States and Germany. Liantao Li's co-authors include Guan Jiang, Jun Zheng, Qian Chen, Junnian Zheng, Huizhong Li, Junnian Zheng, Junping Wen, Qing Zhang, Gang Chen and Baofu Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Liantao Li

110 papers receiving 2.9k citations

Hit Papers

Ki67 is a promising molecular target in the diagnosis of ... 2014 2026 2018 2022 2014 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liantao Li China 27 1.2k 869 567 368 280 115 2.9k
Jie Liu China 32 1.4k 1.2× 1.1k 1.2× 798 1.4× 420 1.1× 381 1.4× 183 3.2k
Fabrice Journé Belgium 35 1.4k 1.2× 1.1k 1.3× 616 1.1× 392 1.1× 353 1.3× 113 3.3k
Qiang Wang China 32 1.6k 1.3× 939 1.1× 557 1.0× 554 1.5× 310 1.1× 151 3.5k
Jawed A. Siddiqui United States 31 1.5k 1.2× 673 0.8× 300 0.5× 353 1.0× 268 1.0× 79 2.8k
Min Hu China 27 1.2k 1.0× 629 0.7× 424 0.7× 651 1.8× 238 0.8× 144 2.8k
Ketao Jin China 29 1.1k 1.0× 849 1.0× 294 0.5× 566 1.5× 290 1.0× 126 2.6k
Christian Ploner Austria 27 1.3k 1.1× 473 0.5× 407 0.7× 436 1.2× 296 1.1× 59 2.5k
Anja van de Stolpe Netherlands 27 1.3k 1.1× 779 0.9× 746 1.3× 673 1.8× 283 1.0× 83 3.3k
Nengtai Ouyang United States 29 1.8k 1.5× 690 0.8× 569 1.0× 614 1.7× 266 0.9× 85 3.5k
Jun Wu China 30 1.7k 1.4× 543 0.6× 566 1.0× 450 1.2× 376 1.3× 155 3.5k

Countries citing papers authored by Liantao Li

Since Specialization
Citations

This map shows the geographic impact of Liantao Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liantao Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liantao Li more than expected).

Fields of papers citing papers by Liantao Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liantao Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liantao Li. The network helps show where Liantao Li may publish in the future.

Co-authorship network of co-authors of Liantao Li

This figure shows the co-authorship network connecting the top 25 collaborators of Liantao Li. A scholar is included among the top collaborators of Liantao Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liantao Li. Liantao Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Li, Liantao, Bo Wang, Yang Zhao, et al.. (2024). FTO blocks RNA translational activity via the loss of N6‐methyladenosine methylation at 5′ UTR regulated by RBM5 in cisplatin‐resistant NSCLC. Journal of Cellular Physiology. 239(8). e31296–e31296. 2 indexed citations
4.
Mao, Yaqian, Liantao Li, Jixing Liang, et al.. (2024). Survival benefit of postoperative radioiodine therapy among patients with intermediate-risk differentiated thyroid carcinoma. Endocrine. 86(2). 664–671. 1 indexed citations
5.
Shi, Yongjie, et al.. (2024). Intelligent fault diagnosis of mechanical engineering using NLF-LSTM optimized deep learning model. Optimization and Engineering. 26(2). 891–912. 6 indexed citations
6.
Huang, Yanling, Yuanyuan Zheng, Liantao Li, et al.. (2019). Association between lifestyle and thyroid dysfunction: a cross-sectional epidemiologic study in the She ethnic minority group of Fujian Province in China. BMC Endocrine Disorders. 19(1). 83–83. 17 indexed citations
7.
Lin, Miao, Huibin Huang, Jin Yao, et al.. (2019). Association between Depression and Renal Hyperfiltration in a General Chinese Population. Kidney & Blood Pressure Research. 44(6). 1441–1452. 5 indexed citations
9.
Wen, Junping, Ting Xue, Ying Huang, et al.. (2016). Is β‐cell aging involved in the pathogenesis of diabetes?. Journal of Diabetes. 9(7). 707–716. 8 indexed citations
10.
Xu, Jixiong, et al.. (2015). IGFBP-3 A-202C and C2133G polymorphisms and colorectal cancer risk: a meta-analysis of case-control studies. Genetics and Molecular Research. 14(2). 3370–3386. 1 indexed citations
11.
Tian, Hui, Baofu Zhang, Huizhong Li, et al.. (2014). Melanoma Differentiation Associated Gene-7/Interleukin-24 Induces Caspase-3 Denitrosylation to Facilitate the Activation of Cancer Cell Apoptosis. Journal of Interferon & Cytokine Research. 35(3). 157–167. 15 indexed citations
12.
Jiang, Guan, Aijun Jiang, Yong Xin, et al.. (2014). Progression of O6-methylguanine-DNA methyltransferase and temozolomide resistance in cancer research. Molecular Biology Reports. 41(10). 6659–6665. 17 indexed citations
13.
Jiang, Guan, Aijun Jiang, Qian Cheng, et al.. (2013). A dual-regulated oncolytic adenovirus expressing interleukin-24 sensitizes melanoma cells to temozolomide via the induction of apoptosis. Tumor Biology. 34(2). 1263–1271. 16 indexed citations
14.
Pei, Dong‐Sheng, Zhi‐Xia Yang, Baofu Zhang, et al.. (2012). Enhanced Apoptosis-Inducing Function of MDA-7/IL-24 RGD Mutant Via the Increased Adhesion to Tumor Cells. Journal of Interferon & Cytokine Research. 32(2). 66–73. 13 indexed citations
15.
Liu, Junjie, Lin Fang, Qian Cheng, et al.. (2012). Effects of G250 promoter controlled conditionally replicative adenovirus expressing Ki67‐siRNA on renal cancer cell. Cancer Science. 103(10). 1880–1888. 16 indexed citations
16.
Wang, Meijuan, Dong‐Sheng Pei, Xiaoxing Yin, et al.. (2011). p53 regulates Ki-67 promoter activity through p53- and Sp1-dependent manner in HeLa cells. Tumor Biology. 32(5). 905–912. 15 indexed citations
17.
Yang, De, Juan Tao, Liantao Li, et al.. (2011). RasGRP3, a Ras activator, contributes to signaling and the tumorigenic phenotype in human melanoma. Oncogene. 30(45). 4590–4600. 31 indexed citations
18.
Li, Liantao, et al.. (2008). The Beneficial Effects of the Herbal Medicine Free and Easy Wanderer Plus (FEWP) and Fluoxetine on Post-Stroke Depression. The Journal of Alternative and Complementary Medicine. 14(7). 841–846. 33 indexed citations
19.
Miyamoto, M, Liantao Li, M Kadoya, et al.. (2006). Immunohistochemical analysis of nuclear survivin expression in esophageal squamous cell carcinoma. Diseases of the Esophagus. 19(5). 355–359. 18 indexed citations
20.
Schneider, Erich, Matthias Mayer, Liantao Li, et al.. (2006). A Simple and Powerful Flow Cytometric Method for the Simultaneous Determination of Multiple Parameters at G Protein‐Coupled Receptor Subtypes. ChemBioChem. 7(9). 1400–1409. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026